President Donald Trump’s company is looking to get back on its feet after losing $3.9 billion last year to a new company called Pharmascience.Pharmascientics is a subsidiary of Pharmacymark Corp., the company that has been struggling to make a dent in the U.S. drug market.PharmacyMark said it was the only major U.K. company in the […]